Cardiff Oncology, Inc. (CRDF) Financials

CRDF Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 88.5 million 10.6 million
2023-06-30 97.5 million 10.9 million
2023-03-31 106.5 million 10.0 million
2022-12-31 116.2 million 9.8 million

CRDF Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -8.3 million 955000
2023-06-30 -7.4 million 1.6 million
2023-03-31 -8.7 million 1.1 million
2022-12-31 -9.5 million 1.0 million

CRDF Net Income

No data available :(

CRDF Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 81.4 million - 2.3 million
2023-06-30 89.4 million - 2.4 million
2023-03-31 97.0 million - 2.6 million
2022-12-31 105.3 million - 2.7 million

CRDF Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 44.7 million
2023-06-30 44.7 million
2023-03-31 44.7 million
2022-12-31 43.6 million

CRDF Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 315000 8.0 million 2.9 million -
2023-06-30 251000 8.0 million 4.3 million -
2023-03-31 8000 9.1 million 3.1 million -
2022-12-31 75000 6.4 million 3.1 million -

CRDF Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 141000 -
2023-06-30 108000 -
2023-03-31 83000 -
2022-12-31 128000 -

CRDF

Price: $4.07

52 week price:
0.94
6.42

Earnings Per Share: -0.93 USD

P/E Ratio: -1.97

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 531000

Market Capitalization: 252.9 million

Links: